a trial was undertaken to ascertain the effect and acceptability of a multiple insulin injection regimen ( mii ) in patients with insulin-dependent diabetes mellitus using short-acting monocomponent human soluble insulin ( actrapid hm ; novo ) for pre-meal bolus injections with the novopen injection device ( novo ) and long-acting human insulin ( ultratard hm ; novo ) at bedtime .
C0011854
insulin-dependent diabetes
C0795635
human soluble insulin